Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) Short Interest Update

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) was the recipient of a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 76,600 shares, an increase of 153.6% from the February 28th total of 30,200 shares. Based on an average daily volume of 447,700 shares, the short-interest ratio is currently 0.2 days.

Ono Pharmaceutical Trading Up 1.4 %

Shares of OPHLY traded up $0.05 during midday trading on Thursday, reaching $3.69. 232,067 shares of the company were exchanged, compared to its average volume of 434,045. Ono Pharmaceutical has a 1-year low of $3.21 and a 1-year high of $5.54. The stock has a 50-day moving average price of $3.50 and a 200-day moving average price of $3.82.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.